LONDON/COPENHAGEN – On Friday, Novo Nordisk (NYSE: NVO) shareholders sought to find out why such a high number of patients
1 year ago
The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals (NASDAQ: IONS) drug to treat a rare genetic disorder, making
SHANGHAI – As Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) expand sales of their popular diabetes and weight-loss
On Wednesday, the U.S. Food and Drug Administration approved Mesoblast’s (NASDAQ: MESO) cell therapy for treating a type of complication
ZURICH – On Thursday, Novartis (NYSE: NVS), the Swiss pharmaceutical group, said it was winding up MorphoSys sites in Germany
On Wednesday, the U.S. Food and Drug Administration classified a recall of Boston Scientific’s (NYSE: BSX) catheters used in a
On Wednesday, the U.S. Department of Justice announced a lawsuit accusing CVS Health (NYSE: CVS) of filling and billing federal
Wall Street analysts said on Wednesday that healthcare provisions in a stopgap bill unveiled by top Republicans and Democrats are
Shares of health insurers operating pharmacy benefit managers fell on Monday after U.S. President-elect Donald Trump called them middlemen who
Powerful weight-loss drugs are expanding the use of U.S. health care as patients starting prescriptions are diagnosed with obesity-related conditions
STOCKHOLM/LONDON – Novo Nordisk (NYSE: NVO), the Danish drugmaker, will invest 8.5 billion crowns ($1.20 billion) in a new facility
On Thursday, Gilead Sciences (NASDAQ: GILD) said it has appointed Sanofi’s (NASDAQ: SNY) Dietmar Berger as its chief medical officer,
